Symptom burden of chronic lung disease compared with lung cancer at time of referral for palliative care consultation

Annals of the American Thoracic Society

Volumn 12, Issue 9, 2015, Pages 1294-1301

  Wysham, Nicholas G ^a,b,c   Cox, Christopher E ^a,c   Wolf, Steven P ^b,d   Kamal, Arif H ^b,e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of Medical Oncology   (United States)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Palliative care

Indexed keywords

AGED; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC LUNG DISEASE; COMPARATIVE STUDY; CONSULTATION; DYSPNEA; FEMALE; HUMAN; INTENSIVE CARE UNIT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PAIN; PALLIATIVE THERAPY; PATIENT REFERRAL; PROGNOSIS; SURVIVAL TIME; SYMPTOM; TOTAL QUALITY MANAGEMENT; ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMPLICATION; LUNG TUMOR; MIDDLE AGED; MULTICENTER STUDY; QUALITY OF LIFE; STANDARDS; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DYSPNEA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 84942278799     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201503-180OC     Document Type: Article

References (45)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
2. Jamal A, Agaku IT, O'Connor E, King BA, Kenemer JB, Neff L. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb Mortal Wkly Rep 2014; 63: 1108-1112.
3. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief 2011; 63: 1-8.
4. Russell RE. Chronic obstructive pulmonary disease: Getting it right: Does optimal management of chronic obstructive pulmonary disease alter disease progression and improve survival? Curr Opin Pulm Med 2014; 20: 127-131.
5. Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease: A potential role for specialist palliative care? Ann Am Thorac Soc 2014; 11: 1433-1438.
6. Figueiredo D, Gabriel R, Jácome C, Cruz J, Marques A. Caring for relatives with chronic obstructive pulmonary disease: How does the disease severity impact on family carers? Aging Ment Health 2014; 18: 385-393.
7. Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med 2006; 166: 326-331.
8. Goodridge D, Lawson J, Duggleby W, Marciniuk D, Rennie D, Stang M. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med 2008; 102: 885-891.
9. Claessens MT, Lynn J, Zhong Z, Desbiens NA, Phillips RS, Wu AW, Harrell FE Jr, Connors AF Jr; Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Dying with lung cancer or chronic obstructive pulmonary disease: Insights from SUPPORT. J Am Geriatr Soc 2000; 48(5 Suppl): S146-S153.
10. Hajizadeh N, Goldfeld K, Crothers K. What happens to patients with COPD with long-Term oxygen treatment who receive mechanical ventilation for COPD exacerbation? A 1-year retrospective follow-up study. Thorax 2015; 70: 294-296.
11. Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, Levy M, Mularski RA, Osborne ML, Prendergast TJ, et al.; ATS End-of-Life Care Task Force. An official American Thoracic Society clinical policy statement: Palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008; 177: 912-927.
12. Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur Respir J 2008; 32: 796-803.
13. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
14. Quill TE, Abernethy AP. Generalist plus specialist palliative care-creating a more sustainable model. N Engl J Med 2013; 368: 1173-1175.
15. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, Ferrell BR, Loscalzo M, Meier DE, Paice JA, et al. American Society of Clinical Oncology provisional clinical opinion: The integration of palliative care into standard oncology care. J Clin Oncol 2012; 30: 880-887.
16. Epiphaniou E, Shipman C, Harding R, Mason B, Murray SA, Higginson IJ, Daveson BA. Coordination of end-of-life care for patients with lung cancer and those with advanced COPD: Are there transferable lessons? A longitudinal qualitative study. Prim Care Respir J 2014; 23: 46-51.
17. Berkhof FF, Hesselink AM, Vaessen DL, Uil SM, Kerstjens HA, van den Berg JW. The effect of an outpatient care on-demand-system on health status and costs in patients with COPD: A randomized trial. Respir Med 2014; 108: 1163-1170.
18. Hussey PS, Schneider EC, Rudin RS, Fox DS, Lai J, Pollack CE. Continuity and the costs of care for chronic disease. JAMA Intern Med 2014; 174: 742-748.
19. Wysham NG, Wolf SP, Kamal AH. The symptom burden of patients with non-malignant lung disease as compared to lung cancer: Lessons from a learning health system in palliative care [abstract]. Am J Respir Crit Care Med 2015; 191(Meeting Abstracts): A3913.
20. Olsen LA, Aisner D, McGinnis JM, editors. The learning healthcare system: Workshop summary. Washington, DC: National Academies Press; 2007.
21. Grossmann C, Powers B, McGinnis JM, editors. Digital infrastructure for the learning health system: The foundation for continuous improvement in health and health care: Workshop series summary. Washington, DC: National Academies Press; 2011.
22. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs 1978; 1: 373-378.
23. Cohen SR, Mount BM, Strobel MG, Bui F. The McGill Quality of Life Questionnaire: A measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 1995; 9: 207-219.
24. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med 2001; 15: 287-295.
25. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55: 1000-1006.
26. Habraken JM, ter Riet G, Gore JM, Greenstone MA, Weersink EJ, Bindels PJ, Willems DL. Health-related quality of life in end-stage COPD and lung cancer patients. J Pain Symptom Manage 2009; 37: 973-981.
27. Walke LM, Gallo WT, Tinetti ME, Fried TR. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 2004; 164: 2321-2324.
28. Steinhauser KE, Arnold RM, Olsen MK, Lindquist J, Hays J, Wood LL, Burton AM, Tulsky JA. Comparing three life-limiting diseases: Does diagnosis matter or is sick, sick? J Pain Symptom Manage 2011; 42: 331-341.
29. Marsteller JA, Sexton JB, Hsu YJ, Hsiao CJ, Holzmueller CG, Pronovost PJ, Thompson DA. A multicenter, phased, clusterrandomized controlled trial to reduce central line-Associated bloodstream infections in intensive care units. Crit Care Med 2012; 40: 2933-2939.
30. Bliss LA, Ross-Richardson CB, Sanzari LJ, Shapiro DS, Lukianoff AE, Bernstein BA, Ellner SJ. Thirty-day outcomes support implementation of a surgical safety checklist. J Am Coll Surg 2012; 215: 766-776.
31. Lupu D; American Academy of Hospice and Palliative Medicine Workforce Task Force. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage 2010; 40: 899-911.
32. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 2004; 22: 3485-3490.
33. Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, Scher HI, Schrag D. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study. Lancet Oncol 2006; 7: 903-909.
34. Abernethy AP, Herndon JE II, Wheeler JL, Patwardhan M, Shaw H, Lyerly HK, Weinfurt K. Improving health care efficiency and quality using tablet personal computers to collect research-quality, patientreported data. Health Serv Res 2008; 43: 1975-1991.
35. Abernethy AP, Ahmad A, Zafar SY, Wheeler JL, Reese JB, Lyerly HK. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care 2010; 48(6 Suppl): S32-S38.
36. Currow DC, Abernethy AP. Therapeutic nihilism: The next hurdle in improving the treatment of breathlessness. Curr Opin Support Palliat Care 2011; 5: 69-70.
37. Rocker G, Young J, Donahue M, Farquhar M, Simpson C. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease. CMAJ 2012; 184: E497-E504.
38. Young J, Donahue M, Farquhar M, Simpson C, Rocker G. Using opioids to treat dyspnea in advanced COPD: Attitudes and experiences of family physicians and respiratory therapists. Can Fam Physician 2012; 58: E401-e407.
39. Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O'Donnell DE, Maltais F, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J 2011; 18: 69-78.
40. Currow DC, Abernethy AP. Pharmacological management of dyspnoea. Curr Opin Support Palliat Care 2007; 1: 96-101.
41. Ekström MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: National prospective study. BMJ 2014; 348: G445.
42. Varkey B. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010; 16: 150-154.
43. Mahler DA, O'Donnell DE. Recent advances in dyspnea. Chest 2015; 147: 232-241.
44. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
45. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, et al. Healthrelated quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685.